NO931561D0 - APPLICATION OF INHIBITORS OF PLASMINOGEN ACTIVATORS FOR TREATMENT OF INFLAMMATION AND SCARS - Google Patents

APPLICATION OF INHIBITORS OF PLASMINOGEN ACTIVATORS FOR TREATMENT OF INFLAMMATION AND SCARS

Info

Publication number
NO931561D0
NO931561D0 NO931561A NO931561A NO931561D0 NO 931561 D0 NO931561 D0 NO 931561D0 NO 931561 A NO931561 A NO 931561A NO 931561 A NO931561 A NO 931561A NO 931561 D0 NO931561 D0 NO 931561D0
Authority
NO
Norway
Prior art keywords
scars
inflammation
inhibitors
treatment
application
Prior art date
Application number
NO931561A
Other languages
Norwegian (no)
Other versions
NO931561L (en
Inventor
Eckhard Schueler
Juergen Roemisch
Eric-Paul Paques
Gerhard Dickneite
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of NO931561D0 publication Critical patent/NO931561D0/en
Publication of NO931561L publication Critical patent/NO931561L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
NO93931561A 1992-04-30 1993-04-29 APPLICATION OF INHIBITORS OF PLASMINOGEN ACTIVATORS FOR TREATMENT OF INFLAMMATION AND SCARS NO931561L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4214215A DE4214215A1 (en) 1992-04-30 1992-04-30 USE OF INHIBITORS OF PLASMINOGEN ACTIVATORS FOR TREATING INFLAMMATION

Publications (2)

Publication Number Publication Date
NO931561D0 true NO931561D0 (en) 1993-04-29
NO931561L NO931561L (en) 1993-11-01

Family

ID=6457814

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931561A NO931561L (en) 1992-04-30 1993-04-29 APPLICATION OF INHIBITORS OF PLASMINOGEN ACTIVATORS FOR TREATMENT OF INFLAMMATION AND SCARS

Country Status (16)

Country Link
EP (1) EP0567816A1 (en)
JP (1) JPH069425A (en)
KR (1) KR930021179A (en)
CN (1) CN1080873A (en)
AU (1) AU3822993A (en)
CA (1) CA2095207A1 (en)
CZ (1) CZ76893A3 (en)
DE (1) DE4214215A1 (en)
HU (1) HUT65755A (en)
IL (1) IL105521A0 (en)
MX (1) MX9302519A (en)
NO (1) NO931561L (en)
PL (1) PL298748A1 (en)
SK (1) SK41593A3 (en)
UY (1) UY23572A1 (en)
ZA (1) ZA933023B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5468505A (en) * 1992-02-28 1995-11-21 Board Of Regents, The University Of Texas System Local delivery of fibrinolysis enhancing agents
GB2271507A (en) * 1992-09-04 1994-04-20 Summit Technology Ireland Bv Compositions containing plasmin activity inhibitors
DE69435002T2 (en) * 1993-07-19 2008-03-20 Angiotech Pharmaceuticals, Inc., Vancouver Anti-angiogenic agents containing taxol and a non-biodegradable carrier and their use
US5994341A (en) * 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
US6558798B2 (en) 1995-02-22 2003-05-06 Scimed Life Systems, Inc. Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity
US5939525A (en) * 1995-03-27 1999-08-17 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US20040254635A1 (en) 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
AU1170899A (en) * 1998-04-01 1999-10-18 Biotech Australia Pty Limited Use of protease inhibitors for treating skin wounds
US6293967B1 (en) 1998-10-29 2001-09-25 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6120847A (en) * 1999-01-08 2000-09-19 Scimed Life Systems, Inc. Surface treatment method for stent coating
US6419692B1 (en) 1999-02-03 2002-07-16 Scimed Life Systems, Inc. Surface protection method for stents and balloon catheters for drug delivery
EP1173198B1 (en) * 1999-04-29 2003-11-19 Ista Pharmaceuticals, Inc Use of a determined hyaluronidase to eliminate corneal scars, opacification and haze
US6156373A (en) * 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
US6258121B1 (en) 1999-07-02 2001-07-10 Scimed Life Systems, Inc. Stent coating
JP3690720B2 (en) 1999-09-14 2005-08-31 インターナショナル・ビジネス・マシーンズ・コーポレーション Client server system, object pooling method, and storage medium
JP2003512436A (en) 1999-10-27 2003-04-02 アレクサンドラ ルーカス、 Compositions and methods for preventing and treating graft rejection
JP2001247458A (en) * 2000-03-08 2001-09-11 Hamari Chemicals Ltd Therapeutic agent for diabetes comprising zinc tranexmate compound
JP2004509171A (en) 2000-09-29 2004-03-25 ゾーン、　ロバート　ズィー． Method and composition for treating inflammation and immune response
EP1935380B1 (en) 2000-10-16 2010-05-12 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6764507B2 (en) 2000-10-16 2004-07-20 Conor Medsystems, Inc. Expandable medical device with improved spatial distribution
US20040073294A1 (en) 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
AT500019B1 (en) * 2001-06-27 2007-06-15 Inst Gefaessbiologie Und Throm USE IN VITRO OF THE TRANSCRIPTION FACTOR NAK-1 OR NAK-1 REGULATED GENES FOR THE DIAGNOSIS OF INFLAMMATORY AND MALIGNIC DISEASES
GB0126389D0 (en) * 2001-11-02 2002-01-02 Pfizer Ltd Wafer
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
US20090202524A1 (en) * 2007-10-31 2009-08-13 Alcon Research, Ltd. Pai-1 expression and activity inhibitors for the treatment of ocular disorders
WO2009093119A2 (en) * 2008-01-21 2009-07-30 Med Discovery S.A. Use of serine protease inhibitors in the treatment of skin diseases
TWI763960B (en) * 2017-12-15 2022-05-11 大陸商深圳瑞健生命科學研究院有限公司 Method and medicine for preventing or treating osteoarthritis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3829523A1 (en) * 1988-08-31 1990-03-01 Behringwerke Ag USE OF PLASMINOGEN ACTIVATOR INHIBITOR (PAI-2) FOR IMMUNE SUPPRESSION
US5444153A (en) * 1989-12-20 1995-08-22 Biotech Australia Pty Limited Variants of PAI-2
EP0451130A3 (en) * 1990-04-05 1992-08-05 Baltimore Biotech, Inc. Use of amiloride and other pyrazine derivatives for preventing or treating ocular neovascularization

Also Published As

Publication number Publication date
PL298748A1 (en) 1993-12-27
CZ76893A3 (en) 1994-01-19
ZA933023B (en) 1994-10-31
UY23572A1 (en) 1993-05-04
EP0567816A1 (en) 1993-11-03
SK41593A3 (en) 1993-11-10
AU3822993A (en) 1993-11-04
HUT65755A (en) 1994-07-28
DE4214215A1 (en) 1993-11-04
HU9301272D0 (en) 1993-07-28
CN1080873A (en) 1994-01-19
MX9302519A (en) 1993-10-01
CA2095207A1 (en) 1993-10-31
IL105521A0 (en) 1993-08-18
JPH069425A (en) 1994-01-18
KR930021179A (en) 1993-11-22
NO931561L (en) 1993-11-01

Similar Documents

Publication Publication Date Title
NO931561D0 (en) APPLICATION OF INHIBITORS OF PLASMINOGEN ACTIVATORS FOR TREATMENT OF INFLAMMATION AND SCARS
HU9303218D0 (en) Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia
PL334250A1 (en) Nitrogen containing hetero-aromatic compounds and inhibitors of xa factor
NO971015D0 (en) Compounds and Methods for the Treatment of Cancer
PL333505A1 (en) Benzamido-aldehydes and their application as inhibitors of cysteinic proteases
NO943353D0 (en) Combinations of ACE inhibitors and diuretics
NO930681D0 (en) PROCEDURE AND DEVICE FOR NON-CONTACT PLASMA POLISHING AND EQUALIZATION OF UNIFORM THINED SUBSTRATES
DK0596122T3 (en) Method of wrapping and wrapping object
IS4805A (en) Method of treatment and pharmaceutical composition
NO965563D0 (en) Treatment and prophylaxis of osteoporosis
NO971900D0 (en) Mixtures and treatment of multiple sclerosis
NO931779D0 (en) PROCEDURE FOR TREATMENT OF CONDENSATES OF AMMONIA AND UREA
NO985214D0 (en) Inhibitors for production of s-CD23 and secretion of TNF
NO960242D0 (en) Procedure for deactivation and destruction of microorganisms
NO172838C (en) PROCEDURE AND PLANT FOR TREATMENT OF WASTE PRODUCTS
NO932342D0 (en) PROCEDURE AND DEVICE FOR PACKAGING WITH AMORPH STEEL STRIPS FOR PRODUCTION OF TRANSFORMER SCREENS
NO952568D0 (en) Treatment of cellulose material and compositions for use therefor
IL111501A0 (en) Pharmaceutical compositions comprising lys-plasminogen and tissue plasminogen activator (t-PA) for the treatment of coronary thrombosis
NO961113D0 (en) Treatment and prevention of prostate cancer
NO951932D0 (en) Treatment of infertility and increase of fertilization capacities
NO970118D0 (en) Compound and method of treating hair loss
AU612562B2 (en) A composition comprising a plasmin inhibitor and a plasminogen activator for the treatment of thrombosis
NO950778L (en) Cloning and expression of
NO934599D0 (en) Procedure and device for reduction of skin tissue
AU3286893A (en) Therapeutic device and method of treatment